Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 50351-50400 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06239298
A Study of ZG005 Combined With Donafenib in Patients With Advanced Solid Tumor
PHASE1/PHASE2Recruiting
130 participants
Started: May 10, 2024 · Completed: May 31, 2026
1 condition1 sponsor1 location
NCT06499051
Epidemiology of French Sexual Offenders. A Cross-sectional Study
N/ARecruiting
400 participants
Started: May 10, 2024 · Completed: Sep 1, 2027
1 condition1 sponsor1 location
NCT06396897
Hospital @ Home Model of Care for Cirrhosis
NARecruiting
30 participants
Started: May 10, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06385366
Developing & Evaluating Models for Early Predicting Obstetrical Diseases in Pregnant Women by Non-invasive Prenatal Test
N/AEnrolling by invitation
1,105 participants
Started: May 10, 2024 · Completed: Nov 6, 2025
4 conditions2 sponsors1 location
NCT06405997
The Genotype and Phenotype of Lymphangioleiomyomatosis
N/ARecruiting
100 participants
Started: May 10, 2024 · Completed: Jul 31, 2027
2 conditions1 sponsor1 location
NCT05793294
Child Health, Nutrition and Microbiome Development
N/ARecruiting
70 participants
Started: May 10, 2024 · Completed: May 31, 2026
5 conditions5 sponsors2 locations
NCT05233527
Novosyn® Quick in Patients Undergoing Episiotomy Closure
N/ARecruiting
300 participants
Started: May 9, 2024 · Completed: May 31, 2026
1 condition2 sponsors1 location
NCT06708234
Frequency of Isthmocele Following Single- Vs Double-layer Uterine Closure.
N/ARecruiting
200 participants
Started: May 9, 2024 · Completed: Nov 30, 2025
1 condition1 sponsor1 location
NCT06298058
A Clinical Trial of SIBP-A13 Injection in the Treatment of Advanced Malignant Solid Tumor Patients.
PHASE1Recruiting
144 participants
Started: May 9, 2024 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT06195605
Investigating Age Dependence of Fibroblast and Extracellular Matrix Responses to Cross-linked Hyaluronic Acid Filler in Human Skin
NARecruiting
15 participants
Started: May 9, 2024 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT06805253
Left Ventricular Reverse Remodeling Evaluation After Surgical Correction of Aortic Regurgitation
N/ARecruiting
120 participants
Started: May 9, 2024 · Completed: May 31, 2030
6 conditions2 sponsors2 locations
NCT06360874
A Study to Evaluate Safety, Tolerability and Pharmacokinetic of ND-003 Tablets in Healthy Adults
PHASE1Enrolling by invitation
104 participants
Started: May 9, 2024 · Completed: Feb 28, 2025
1 condition2 sponsors1 location
NCT06425926
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
PHASE1/PHASE2Recruiting
117 participants
Started: May 9, 2024 · Completed: Nov 30, 2026
2 conditions1 sponsor11 locations
NCT06414083
Histologic Comparison of Ablative Techniques for Endometriosis
NARecruiting
141 participants
Started: May 9, 2024 · Completed: Jun 9, 2025
4 conditions1 sponsor1 location
NCT06312020
A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjogren's Syndrome
PHASE2Recruiting
262 participants
Started: May 9, 2024 · Completed: Feb 9, 2027
1 condition1 sponsor67 locations
NCT06314009
Beyond MARS: Magnetic Resonance Study: A Novel Assessment of Placental Perfusion During Pregnancy
N/ARecruiting
30 participants
Started: May 9, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06462313
Dobutamine for Management of Surgical Patients with Septic Shock
NARecruiting
584 participants
Started: May 9, 2024 · Completed: Apr 30, 2027
3 conditions44 sponsors1 location
NCT06414044
Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients
N/ARecruiting
100 participants
Started: May 9, 2024 · Completed: Apr 30, 2026
4 conditions18 sponsors2 locations
NCT05703971
Quaratusugene Ozeplasmid (Reqorsa) and Atezolizumab Maintenance Therapy in ES-SCLC Patients
PHASE1/PHASE2Recruiting
62 participants
Started: May 9, 2024 · Completed: Aug 31, 2027
1 condition1 sponsor17 locations
NCT06412848
JAVEMACS: Japan AVElumab Maintenance And Continuous Treatment Study
N/AActive, not recruiting
360 participants
Started: May 9, 2024 · Completed: Jun 30, 2026
1 condition1 sponsor26 locations
NCT06369584
Prone Position During ECMO in Pediatric Patients With Severe ARDS
NARecruiting
7 participants
Started: May 9, 2024 · Completed: Jul 1, 2025
2 conditions8 sponsors8 locations
NCT06069999
Telerehabilitation Early After CNS Injury
NAActive, not recruiting
60 participants
Started: May 9, 2024 · Completed: Oct 30, 2025
3 conditions2 sponsors5 locations
NCT06413823
Prevention and Treatment of Cardiovascular Disease
N/ARecruiting
218 participants
Started: May 9, 2024 · Completed: May 13, 2026
1 condition1 sponsor1 location
NCT06856941
CsDCS on Functional Mobility in Parkinsons Disease
NARecruiting
66 participants
Started: May 9, 2024 · Completed: Mar 31, 2026
1 condition1 sponsor1 location
NCT06283212
A Clinical Study to Evaluate the Safety and Efficacy of ETX101, an AAV9-Delivered Gene Therapy in Children With SCN1A-positive Dravet Syndrome
PHASE1/PHASE2Recruiting
4 participants
Started: May 9, 2024 · Completed: Sep 30, 2030
1 condition1 sponsor3 locations
NCT06056102
CAR-T Cell Therapy for Desensitization in Kidney Transplantation
PHASE1Recruiting
20 participants
Started: May 9, 2024 · Completed: Dec 15, 2042
3 conditions2 sponsors3 locations
NCT07028606
Vertical Ridge Augmentation Using Computer-guided Sandwich Osteotomy Technique
PHASE1Active, not recruiting
12 participants
Started: May 9, 2024 · Completed: Jun 10, 2025
1 condition1 sponsor1 location
NCT06218706
LIFU for Treatment for Refractory Opioid Use Disorder
NARecruiting
34 participants
Started: May 9, 2024 · Completed: Mar 1, 2028
1 condition2 sponsors1 location
NCT05675436
Investigating the Mechanistic Effects of Mitapivat in Subjects With Sickle Cell Disease
N/AActive, not recruiting
6 participants
Started: May 9, 2024 · Completed: Oct 27, 2027
8 conditions1 sponsor1 location
NCT06457841
Stress and Resilience
NARecruiting
456 participants
Started: May 9, 2024 · Completed: Jul 31, 2027
2 conditions2 sponsors2 locations
NCT07203612
Tailoring a Home Supervision Intervention for Latinx Caregivers
NARecruiting
100 participants
Started: May 9, 2024 · Completed: Aug 30, 2026
1 condition1 sponsor1 location
NCT06267222
Trans-spinal Electrical Stimulation in Individuals With Spinocerebellar Ataxia
NAEnrolling by invitation
45 participants
Started: May 9, 2024 · Completed: Jul 31, 2024
3 conditions2 sponsors1 location
NCT07024745
PrEP US NoW: PrEP Utilization Through Increasing Social Capital Among YBMSM Networks With Women
NAEnrolling by invitation
66 participants
Started: May 9, 2024 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT06268951
Recovery and Symptom Relief Following Percutaneous Ablation of Abdominal Wall Endometriosis
N/AEnrolling by invitation
50 participants
Started: May 9, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT06646809
Reducing Inflammatory Syndrome in Surgery - Colorectal (RISIS-CR) Trial
PHASE3Recruiting
80 participants
Started: May 9, 2024 · Completed: Dec 31, 2024
1 condition2 sponsors4 locations
NCT06310278
Ossiview Normative Mobility Data Collection Protocol
N/ARecruiting
120 participants
Started: May 9, 2024 · Completed: Oct 31, 2024
1 condition1 sponsor1 location
NCT06369857
Pectopexy for Apical Prolapse Management
NARecruiting
10 participants
Started: May 9, 2024 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT06326983
Opioid Sparing Anesthesia Care for Pediatric Patients Having Tonsil Surgery
NARecruiting
58 participants
Started: May 9, 2024 · Completed: Apr 1, 2026
6 conditions1 sponsor1 location
NCT06546397
Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced Abortion
PHASE1Recruiting
200 participants
Started: May 9, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06439576
Real World Evidence in China: Faricimab Use in Diabetic Macular Edema, Retinal Vein Occlusion, and Neovascular Age-Related Macular Degeneration (The Farseeing Study)
N/ARecruiting
1,000 participants
Started: May 9, 2024 · Completed: Nov 30, 2027
3 conditions2 sponsors6 locations
NCT06436677
A Study of Molecular Subtyping-based Therapeutic Strategies for Cutaneous T-cell Lymphoma
N/ARecruiting
100 participants
Started: May 9, 2024 · Completed: Dec 31, 2030
2 conditions3 sponsors3 locations
NCT06223269
Safety and Efficacy of realSKIN® to Provide Complete Wound Closure of Burn Wounds as an Alternative to Autografting
PHASE3Recruiting
50 participants
Started: May 9, 2024 · Completed: Jan 31, 2026
5 conditions2 sponsors4 locations
NCT06722508
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
NARecruiting
20 participants
Started: May 9, 2024 · Completed: Dec 31, 2025
4 conditions1 sponsor2 locations
NCT06457633
Effectiveness of Experiential Fibrowalk Therapy
NAActive, not recruiting
120 participants
Started: May 9, 2024 · Completed: Oct 30, 2024
1 condition2 sponsors1 location
NCT07165626
Evaluation of Retinal Parameters in Patients With Epiretinal Membrane After Vitrectomy
NAEnrolling by invitation
100 participants
Started: May 9, 2024 · Completed: Apr 30, 2027
4 conditions1 sponsor1 location
NCT06609525
Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects
PHASE2/PHASE3Recruiting
156 participants
Started: May 9, 2024 · Completed: Mar 1, 2025
1 condition1 sponsor1 location
NCT05965362
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR)
N/ARecruiting
2,000 participants
Started: May 9, 2024 · Completed: Dec 31, 2028
1 condition5 sponsors1 location
NCT06395870
Targeting CD19/CD20 Dual-targeted Cell in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma
PHASE1Recruiting
33 participants
Started: May 9, 2024 · Completed: Jun 30, 2028
2 conditions2 sponsors2 locations
NCT06412562
M3VAS Validation in Polish Population
N/ARecruiting
150 participants
Started: May 9, 2024 · Completed: Sep 30, 2026
1 condition2 sponsors1 location
NCT06352320
Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH)
N/ARecruiting
500 participants
Started: May 9, 2024 · Completed: Aug 31, 2032
1 condition1 sponsor1 location